SBIO (ALPS Medical Breakthroughs ETF) Stock Analysis - News

ALPS Medical Breakthroughs ETF (SBIO) is a publicly traded the market company. As of May 21, 2026, SBIO trades at $58.43 with a market cap of $0 and a P/E ratio of 0.00. SBIO moved +0.00% today. Year to date, SBIO is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces SBIO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What changed in SBIO news today?

Rallies tracks the latest SBIO news, catalysts, market updates, source links, and AI summaries when news is available.

SBIO Key Metrics

Key financial metrics for SBIO
MetricValue
Price$58.43
Market Cap$0
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$0.00
52-Week Low$0.00
Volume114.58K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

SBIO Analyst Consensus

SBIO analyst coverage data. Average price target: $0.00.

Common questions about SBIO

What changed in SBIO news today?
Rallies tracks the latest SBIO news, catalysts, market updates, source links, and AI summaries when news is available.
Does Rallies summarize SBIO news?
Yes. Rallies summarizes SBIO news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is SBIO research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SBIO. It does not provide personalized investment advice.
SBIO

SBIO